Soleno Therapeutics, Inc. (NASDAQ: SLNO) reported Q4 EPS of ($0.33), $0.06 worse than the analyst estimate of ($0.27).

For earnings history and earnings-related data on Soleno Therapeutics, Inc. (SLNO) click here.